Medically reviewed by Cordelia Nwankwo, MD An uncomplicated urinary tract infection (UTI) can sometimes go away on its own ...

GSK's pill, the first oral antibiotic for urinary tract infections in almost 30 years, comes as bacteria are increasingly ...

A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...

This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...

GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...

UTI symptoms can linger after a round of antibiotic treatment. This may happen if you have another type of infection with similar symptoms or need a different kind of treatment. Doctors typically ...

Although the long-term sequelae from UTI-related scarring has been debated, prompt diagnosis and institution of effective treatment remain a clinical priority. Because the clinical presentation of ...

The approval marks a vital step toward care for urinary tract infections, helping to reduce recurrence and improve patients’ quality of life. The FDA has approved gepotidacin (Blujepa; GSK), for use ...

How significant is the approval of gepotidacin for the treatment of uncomplicated urinary tract infections in female adults and adolescents? I think the value for uncomplicated UTIs is still really ...